United States

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

24 May 2017
Change (% chg)

¥0 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4519.T


CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as... (more)


Beta: 0.64
Market Cap(Mil.): ¥2,364,673.00
Shares Outstanding(Mil.): 559.69
Dividend: 29.00
Yield (%): 1.23


  4519.T Industry Sector
P/E (TTM): 40.13 14.29 17.36
EPS (TTM): 105.28 -- --
ROI: 8.79 -7.57 -5.72
ROE: 9.10 -7.17 -5.10

BRIEF-Chugai Pharmaceutical sells trusted beneficial rights of property

* Says it has sold the trusted beneficial rights of Tokyo-based property on May 12

May 12 2017

BRIEF- Baxalta files lawsuit against Chugai Pharmaceutical and Genentech

* Says Baxalta filed a lawsuit against the company and Genentech Inc., in U.S. on May 4

May 10 2017

BRIEF-Chugai Pharmaceutical to retire treasury shares

* Says it will retire 123,000 shares (0.02 percent of outstanding) of its common stock on April 28

Apr 25 2017

BRIEF-Chugai Pharmaceutical to issue 123,000 shares for 469.9 mln yen

* Says it plans to issue 123,000 shares for 469.9 million yen in total

Mar 23 2017

Swiss stocks - Factors to watch on Jan 16

ZURICH, Jan 16 The Swiss blue-chip SMI was seen opening 0.2 percent easier at 8,436 points on Monday, according to premarket indications by bank Julius Baer .

Jan 16 2017

BRIEF-Chugai, Berlin-Chemie Menarini set license agreement for PA799

* Roche's chugai and Berlin-Chemie Menarini Group announce global license agreement for an anti-cancer agent PA799 Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

Nov 28 2016

More From Around the Web

Earnings vs. Estimates